German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
The rare blood-clotting issues associated with the Astra-Zeneca vaccine have recently made headlines, but it's too early to say whether it will increase overall vaccine hesitancy.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Dummy text